Effects of chronic antagonism of endocannabinoid-1 receptors on glucose tolerance and insulin action in skeletal muscles of lean and obese zucker rats

Katherine A. Lindborg, Stephan Jacob, Erik J. Henriksen

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Background/Aims: Antagonism of the endocannabinoid receptor-1 (CB1R) directly improves whole-body metabolic parameters of insulin resistance. The present investigation determined the effects of chronic CB1R antagonism on whole-body and skeletal-muscle insulin action in insulin-sensitive lean and insulin-resistant obese Zucker rats. Methods: Animals were either fed ad libitum or in pairs, or treated with SR141716 (10 mg/kg i.p. for 14 days). Results: Food intake was significantly reduced (p < 0.05) after initial SR141716 treatment and remained decreased in both lean and obese animals until day 13. Fasting plasma glucose decreased (24%) and insulin increased (43%) in lean SR141716-treated (24%) rats compared to lean ad libitum-fed controls, but not in the corresponding obese groups. Fasting plasma free fatty acids were reduced by CB1R antagonism in lean (21%) and obese (42%) animals. Whole-body insulin sensitivity was increased (36%) in obese SR141716-treated rats compared to obese ad libitum-fed controls, which was associated with reduced insulin secretion during an oral glucose tolerance test. Insulin-stimulated glucose transport activity in the soleus was greatest in the respective SR141716-treated lean and obese groups compared to the corresponding ad libitum- and pair-fed controls. Chronic SR141716 treatment did not induce alterations in signaling factors associated with the regulation of glucose transport [protein kinase B (Akt), glycogen synthase kinase-3β, 5′-AMP-dependent protein kinase, or p38 mitogen-activated protein kinase] in the soleus. Conclusions: These results indicate that, while the chronic treatment with CB1R antagonism markedly diminished food intake in lean and obese Zucker rats, there are also significant metabolic improvements in whole-body and skeletal-muscle insulin action mediated by CB1R antagonism through mechanisms independent of reduced caloric intake.

Original languageEnglish (US)
Pages (from-to)31-44
Number of pages14
JournalCardioRenal Medicine
Volume1
Issue number1
DOIs
StatePublished - Jan 2011

Keywords

  • CB1 receptor
  • Insulin resistance
  • SR141716
  • Soleus muscle
  • Zucker rat

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Urology

Fingerprint Dive into the research topics of 'Effects of chronic antagonism of endocannabinoid-1 receptors on glucose tolerance and insulin action in skeletal muscles of lean and obese zucker rats'. Together they form a unique fingerprint.

Cite this